IASLC Educational Webinars

This webinar provides guidance on billing rules and regulations associated with the revenue cycle processes within the RHC. We will focus on the importance of identifying and resolving obstacles that may keep an organization from meeting goals for best practice benchmarks. Ensuring staff have current policies and procedures for charge capture, claim submission and the collection process ensures consistent, focused efforts in maintaining the accounts receivable.

With the extensive network systems found in the healthcare industry, SSH keys are widely used to provide privileged administrative access and to secure machine-to-machine automation for important business functions. However, SSH keys are routinely untracked, unmanaged and unmonitored. This lack of visibility and control can create HIPAA violations by not adequately restricting access to Electronic Protected Health Information (ePHI). If SSH keys are not surely managed, the organization does not know who has access. In this session, we’ll examine SSH study results that reveal widespread lack of security controls for SSH keys in the healthcare industry. We’ll discuss the common mistakes that almost all healthcare organizations make around security, policy, and auditing practices when managing SSH keys.

This special webinar will provide some thought-provoking questions to help you get ready for the biggest change in long-term care in decades. Beginning October 1, a new case-mix model, the Patient-Driven Payment Model (PDPM), is set to take effect and replace the existing RUG-IV case-mix classification model. Reimbursement will largely shift from rehabilitation services to nursing services. It is essential that skilled nursing facilities consider every care process, from improved nursing assessment skills to a different relationship with their rehab provider.

One of the most promising personalized immunotherapy approaches currently being explored in the clinic is cancer vaccines. These vaccines especially patient-tailored versions known as neoantigen vaccines are capable of educating patients’ immune systems about what their individual tumors look like, and in turn, have the potential to improve the immune system’s ability to target and eliminate cancer.